This result suggests that impaired differentiation of TRM was also evident in the lung of severe COVID-19 patients, which may be implicated with attenuated capacity for viral clearance of CD8+Tc during SARS-COV-2 infection. The gene discussed is CD8A; the disease is COVID-19.